Table 4 Toxicity grading of different treatments after BMs, n (%)
| Â | Chemotherapy | Radiotherapy | Targeted therapy | Targeted combined radiotherapy | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grade 1 | Grade 2 | Grade 3 | Grade 1 | Grade 2 | Grade 3 | Grade 1 | Grade 2 | Grade 3 | Grade 1 | Grade 2 | Grade 3 | |
Weakness | 10 66.7 | 5 33.3 | 0 0.0 | 12 44.4 | 4 14.8 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 20 51.3 | 5 12.8 | 0 0.0 |
Weight loss | 8 53.3 | 2 13.3 | 0 0.0 | 5 18.5 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 8 20.5 | 0 0.0 | 0 0.0 |
Rash | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 7 50.0 | 3 21.4 | 0 0.0 | 16 41.0 | 3 7.7 | 0 0.0 |
Nausea | 8 53.3 | 2 13.3 | 0 0.0 | 10 27.0 | 0 0.0 | 0 0.0 | 4 28.6 | 0 0.0 | 0 0.0 | 10 25.6 | 1 2.6 | 0 0.0 |
Vomiting | 5 33.3 | 2 13.3 | 0 0.0 | 1 3.7 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0v | 0 0.0 | 2 5.1 | 0 0.0 | 0 0.0 |
Diarrhea | 4 26.7 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 4 28.6 | 0 0.0 | 0 0.0 | 8 20.5 | 0 0.0 | 0 0.0v |
Decreased absolute neutrophils value | 5 33.3 | 1 6.7 | 1 6.7 | 5 18.5 | 1 3.7 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 6 15.4 | 2 5.1 | 0 0.0 |
Elevated ALT/AST | 1 6.7 | 1 6.7 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 3 21.4 | 1 7.1 | 0 0.0 | 7 17.9 | 2 5.1 | 0 0.0 |
Elevated bilirubin | 1 6.7 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 5 35.7 | 0 0.0 | 0 0.0 | 4 10.3 | 0 0.0 | 0 0.0 |
Headache | 0 0.0 | 0 0.0 | 0 0.0 | 9 33.3 | 1 3.7 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 12 30.8 | 4 10.3 | 0 0.0 |
Dizziness | 0 0.0 | 0 0.0 | 0 0.0 | 8 29.6 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 0 0.0 | 10 25.6 | 0 0.0 | 0 0.0 |